Aspira Women's Health (AWH) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

AWH Stock Forecast

Aspira Women's Health stock forecast is as follows: an average price target of $3.30 (represents a 331.37% upside from AWH’s last price of $0.77) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

AWH Price Target

The average price target for Aspira Women's Health (AWH) is $3.30 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $3.30 to $3.30. This represents a potential 331.37% upside from AWH's last price of $0.77.

AWH Analyst Ratings

Buy

According to 2 Wall Street analysts, Aspira Women's Health's rating consensus is 'Buy'. The analyst rating breakdown for AWH stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Aspira Women's Health Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Apr 01, 2024	Ross Osborn	Cantor Fitzgerald	$3.30	$3.10	6.45%	331.37%

The latest Aspira Women's Health stock forecast, released on Apr 01, 2024 by Ross Osborn from Cantor Fitzgerald, set a price target of $3.30, which represents a 6.45% increase from the stock price at the time of the forecast ($3.10), and a 331.37% increase from AWH last price ($0.77).

Aspira Women's Health Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$3.30
Last Closing Price	$0.77	$0.77	$0.77
Upside/Downside	-100.00%	-100.00%	331.37%

In the current month, the average price target of Aspira Women's Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Aspira Women's Health's last price of $0.77. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 14, 2024	Alliance Global Partners	Buy	Buy	Hold
Apr 01, 2024	Cantor Fitzgerald	Neutral	Neutral	Hold

Aspira Women's Health's last stock rating was published by Alliance Global Partners on Aug 14, 2024. The company gave AWH a "Buy" rating, the same as its previous rate.

Aspira Women's Health Financial Forecast

Aspira Women's Health Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
Revenue	-	-	-	-	-	-	-	-	-	-	$2.49M	$2.32M	$2.15M	$2.07M	$2.07M	$1.89M	$1.85M	$1.67M	$1.80M	$1.50M	$1.45M	$1.24M	$1.31M	$1.28M	$1.14M	$803.00K	$649.00K	$726.00K	$505.00K	$951.00K
Avg Forecast	$5.41M	$4.77M	$4.00M	$3.77M	$2.85M	$2.78M	$2.73M	$2.56M	$2.53M	$2.91M	$2.80M	$2.56M	$2.25M	$2.45M	$2.40M	$1.96M	$1.85M	$1.60M	$1.65M	$1.37M	$1.30M	$1.13M	$4.20M	$3.80M	$3.20M	$2.30M	$486.75K	$544.50K	$505.00K	$951.00K
High Forecast	$6.15M	$5.42M	$4.55M	$4.28M	$3.24M	$2.81M	$2.73M	$2.91M	$2.88M	$2.91M	$3.18M	$2.91M	$2.56M	$2.45M	$2.40M	$1.96M	$1.85M	$1.60M	$1.65M	$1.37M	$1.30M	$1.13M	$4.20M	$3.80M	$3.20M	$2.30M	$584.10K	$653.40K	$606.00K	$1.14M
Low Forecast	$4.68M	$4.12M	$3.46M	$3.25M	$2.46M	$2.75M	$2.73M	$2.21M	$2.19M	$2.91M	$2.42M	$2.21M	$1.94M	$2.45M	$2.40M	$1.96M	$1.85M	$1.60M	$1.65M	$1.37M	$1.30M	$1.13M	$4.20M	$3.80M	$3.20M	$2.30M	$389.40K	$435.60K	$404.00K	$760.80K
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	9	9	8	8	8	8	10	10	20	10
Surprise %	-	-	-	-	-	-	-	-	-	-	0.89%	0.91%	0.96%	0.85%	0.86%	0.97%	1.00%	1.04%	1.09%	1.09%	1.11%	1.10%	0.31%	0.34%	0.36%	0.35%	1.33%	1.33%	1.00%	1.00%

Aspira Women's Health's average Quarter revenue forecast for Sep 23 based on 1 analysts is $2.91M, with a low forecast of $2.91M, and a high forecast of $2.91M. AWH's average Quarter revenue forecast represents a 16.80% increase compared to the company's last Quarter revenue of $2.49M (Jun 23).

Aspira Women's Health EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	9	9	8	8	8	8	10	10	20	10
EBITDA	-	-	-	-	-	-	-	-	-	-	$-4.32M	$-5.75M	$-6.07M	$-14.63M	$-8.16M	$-9.19M	$-8.85M	$-9.64M	$-6.99M	$-5.83M	$-5.99M	$-4.22M	$-3.33M	$-3.73M	$-4.22M	$-3.58M	$-2.65M	$-2.46M	$-4.75M	$-4.08M
Avg Forecast	$-5.41M	$-4.77M	$-4.00M	$-3.77M	$-2.85M	$-2.78M	$-2.73M	$-11.12M	$-2.53M	$-2.91M	$-2.80M	$-10.10M	$-1.85M	$-2.45M	$-2.40M	$-9.19M	$-1.85M	$-1.60M	$-1.65M	$-8.95M	$-1.30M	$-4.22M	$-4.20M	$-3.80M	$-3.20M	$-2.30M	$-1.99M	$-1.84M	$-4.75M	$-4.08M
High Forecast	$-4.68M	$-4.12M	$-3.46M	$-3.25M	$-2.46M	$-2.75M	$-2.73M	$-8.89M	$-2.19M	$-2.91M	$-2.42M	$-8.08M	$-1.48M	$-2.45M	$-2.40M	$-7.35M	$-1.85M	$-1.60M	$-1.65M	$-7.16M	$-1.30M	$-3.38M	$-4.20M	$-3.80M	$-3.20M	$-2.30M	$-1.59M	$-1.48M	$-3.80M	$-3.27M
Low Forecast	$-6.15M	$-5.42M	$-4.55M	$-4.28M	$-3.24M	$-2.81M	$-2.73M	$-13.34M	$-2.88M	$-2.91M	$-3.18M	$-12.13M	$-2.22M	$-2.45M	$-2.40M	$-11.02M	$-1.85M	$-1.60M	$-1.65M	$-10.74M	$-1.30M	$-5.07M	$-4.20M	$-3.80M	$-3.20M	$-2.30M	$-2.39M	$-2.21M	$-5.70M	$-4.90M
Surprise %	-	-	-	-	-	-	-	-	-	-	1.54%	0.57%	3.28%	5.97%	3.40%	1.00%	4.78%	6.03%	4.24%	0.65%	4.60%	1.00%	0.79%	0.98%	1.32%	1.56%	1.33%	1.33%	1.00%	1.00%

undefined analysts predict AWH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Aspira Women's Health's previous annual EBITDA (undefined) of $NaN.

Aspira Women's Health Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	9	9	8	8	8	8	10	10	20	10
Net Income	-	-	-	-	-	-	-	-	-	-	$-2.32M	$-6.34M	$-4.64M	$581.00K	$-8.27M	$-9.29M	$-9.01M	$-9.71M	$-7.07M	$-5.92M	$-6.08M	$-4.29M	$-3.39M	$-3.82M	$-4.31M	$-3.72M	$-2.85M	$-2.67M	$-4.90M	$-4.14M
Avg Forecast	$-1.80M	$-1.83M	$-2.29M	$-2.43M	$-3.30M	$-3.97M	$-4.83M	$-11.21M	$-6.87M	$-7.81M	$-8.45M	$-10.19M	$-1.89M	$-12.21M	$-13.14M	$-9.27M	$-15.02M	$-13.14M	$-11.27M	$-9.09M	$-6.89M	$-4.29M	$-3.76M	$-3.76M	$-5.63M	$-5.63M	$-2.14M	$-2.00M	$-4.90M	$-4.14M
High Forecast	$-1.48M	$-1.51M	$-1.88M	$-2.00M	$-2.71M	$-3.27M	$-3.97M	$-8.97M	$-5.65M	$-6.43M	$-6.95M	$-8.16M	$-1.51M	$-12.21M	$-13.14M	$-7.41M	$-15.02M	$-13.14M	$-11.27M	$-7.27M	$-6.89M	$-3.43M	$-3.76M	$-3.76M	$-5.63M	$-5.63M	$-1.71M	$-1.60M	$-3.92M	$-3.31M
Low Forecast	$-2.12M	$-2.16M	$-2.69M	$-2.86M	$-3.88M	$-4.67M	$-5.68M	$-13.46M	$-8.09M	$-9.20M	$-9.94M	$-12.23M	$-2.27M	$-12.21M	$-13.14M	$-11.12M	$-15.02M	$-13.14M	$-11.27M	$-10.91M	$-6.89M	$-5.14M	$-3.76M	$-3.76M	$-5.63M	$-5.63M	$-2.56M	$-2.41M	$-5.88M	$-4.96M
Surprise %	-	-	-	-	-	-	-	-	-	-	0.27%	0.62%	2.46%	-0.05%	0.63%	1.00%	0.60%	0.74%	0.63%	0.65%	0.88%	1.00%	0.90%	1.02%	0.77%	0.66%	1.33%	1.33%	1.00%	1.00%

Aspira Women's Health's average Quarter net income forecast for Dec 22 is $-1.89M, with a range of $-2.27M to $-1.51M. AWH's average Quarter net income forecast represents a -425.41% decrease compared to the company's last Quarter net income of $581.00K (Sep 22).

Aspira Women's Health SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	9	9	8	8	8	8	10	10	20	10
SG&A	-	-	-	-	-	-	-	-	-	-	$5.18M	$5.73M	$5.80M	$8.70M	$7.78M	$8.86M	$8.51M	$8.92M	$7.30M	$5.62M	$5.57M	$4.12M	$3.68M	$3.85M	$4.31M	$3.62M	$2.54M	$2.43M	$3.94M	$3.62M
Avg Forecast	$18.99M	$16.74M	$14.03M	$13.21M	$10.01M	$9.75M	$9.59M	$8.99M	$8.88M	$10.21M	$9.82M	$8.97M	$7.89M	$8.60M	$8.42M	$6.87M	$6.49M	$5.61M	$5.79M	$4.80M	$4.57M	$3.95M	$14.74M	$13.33M	$11.23M	$8.07M	$1.71M	$1.91M	$1.77M	$3.34M
High Forecast	$21.58M	$19.02M	$15.95M	$15.01M	$11.37M	$9.85M	$9.59M	$10.22M	$10.10M	$10.21M	$11.16M	$10.19M	$8.96M	$8.60M	$8.42M	$6.87M	$6.49M	$5.61M	$5.79M	$4.80M	$4.57M	$3.95M	$14.74M	$13.33M	$11.23M	$8.07M	$2.05M	$2.29M	$2.13M	$4.00M
Low Forecast	$16.40M	$14.45M	$12.12M	$11.41M	$8.64M	$9.66M	$9.59M	$7.76M	$7.67M	$10.20M	$8.48M	$7.74M	$6.81M	$8.60M	$8.42M	$6.87M	$6.49M	$5.61M	$5.79M	$4.80M	$4.57M	$3.95M	$14.74M	$13.33M	$11.23M	$8.07M	$1.37M	$1.53M	$1.42M	$2.67M
Surprise %	-	-	-	-	-	-	-	-	-	-	0.53%	0.64%	0.74%	1.01%	0.92%	1.29%	1.31%	1.59%	1.26%	1.17%	1.22%	1.04%	0.25%	0.29%	0.38%	0.45%	1.49%	1.27%	2.22%	1.08%

Aspira Women's Health's average Quarter SG&A projection for Sep 23 is $10.21M, based on 1 Wall Street analysts, with a range of $10.20M to $10.21M. The forecast indicates a 97.08% rise compared to AWH last annual SG&A of $5.18M (Jun 23).

Aspira Women's Health EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Dec 19	Sep 19	Jun 19	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
# Analysts	1	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	9	9	8	8	8	8	10	10	20	10
EPS	-	-	-	-	-	-	-	-	-	-	$-0.00	$-0.69	$-0.04	$0.01	$-0.07	$-0.08	$-0.08	$-0.09	$-0.06	$-0.05	$-0.58	$-0.04	$-0.03	$-0.04	$-0.06	$-0.05	$-0.05	$-0.05	$-0.09	$-0.10
Avg Forecast	$-0.12	$-0.12	$-0.15	$-0.16	$-0.21	$-0.26	$-0.31	$-0.33	$-0.45	$-0.51	$-0.55	$-0.75	$-0.99	$-0.97	$-1.05	$-1.20	$-1.20	$-1.05	$-0.90	$-2.60	$-0.55	$-0.60	$-0.30	$-0.30	$-0.45	$-0.45	$-0.03	$-0.03	$-0.09	$-0.10
High Forecast	$-0.10	$-0.10	$-0.12	$-0.13	$-0.18	$-0.21	$-0.26	$-0.27	$-0.37	$-0.42	$-0.45	$-0.62	$-0.81	$-0.97	$-1.05	$-1.20	$-1.20	$-1.05	$-0.90	$-2.60	$-0.55	$-0.60	$-0.30	$-0.30	$-0.45	$-0.45	$-0.02	$-0.02	$-0.07	$-0.08
Low Forecast	$-0.14	$-0.14	$-0.17	$-0.19	$-0.25	$-0.30	$-0.37	$-0.39	$-0.53	$-0.60	$-0.65	$-0.88	$-1.16	$-0.97	$-1.05	$-1.20	$-1.20	$-1.05	$-0.90	$-2.60	$-0.55	$-0.60	$-0.30	$-0.30	$-0.45	$-0.45	$-0.04	$-0.04	$-0.11	$-0.12
Surprise %	-	-	-	-	-	-	-	-	-	-	0.00%	0.92%	0.04%	-0.01%	0.07%	0.07%	0.07%	0.09%	0.07%	0.02%	1.05%	0.07%	0.10%	0.13%	0.13%	0.11%	1.67%	1.67%	1.00%	1.00%

According to 1 Wall Street analysts, Aspira Women's Health's projected average Quarter EPS for Dec 22 is $-0.99, with a low estimate of $-1.16 and a high estimate of $-0.81. This represents a -19885.00% decrease compared to AWH previous annual EPS of $0.01 (Sep 22).

Aspira Women's Health Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
DRIO	DarioHealth	$0.71	$10.75	1414.08%	Buy
STIM	Neuronetics	$1.30	$8.00	515.38%	Buy
AWH	Aspira Women's Health	$0.75	$3.30	340.00%	Buy
BDSX	Biodesix	$1.39	$3.00	115.83%	Buy
RDNT	RadNet	$76.52	$91.00	18.92%	Buy
XGN	Exagen	$5.80	$5.00	-13.79%	Buy

AWH Forecast FAQ

Is Aspira Women's Health a good buy?

Yes, according to 2 Wall Street analysts, Aspira Women's Health (AWH) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of AWH's total ratings.

What is AWH's price target?

Aspira Women's Health (AWH) average price target is $3.3 with a range of $3.3 to $3.3, implying a 331.37% from its last price of $0.765. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Aspira Women's Health stock go up soon?

According to Wall Street analysts' prediction for AWH stock, the company can go up by 331.37% (from the last price of $0.765 to the average price target of $3.3), up by 331.37% based on the highest stock price target, and up by 331.37% based on the lowest stock price target.

Can Aspira Women's Health stock reach $1?

AWH's average twelve months analyst stock price target of $3.3 supports the claim that Aspira Women's Health can reach $1 in the near future.

What are Aspira Women's Health's analysts' financial forecasts?

Aspira Women's Health's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $10.93M (high $11.7M, low $10.17M), average EBITDA is $-19.483M (high $-16.845M, low $-22.121M), average net income is $-23.31M (high $-18.923M, low $-27.697M), average SG&A $38.34M (high $41.02M, low $35.66M), and average EPS is $-1.118 (high $-0.92, low $-1.316). AWH's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $17.95M (high $20.4M, low $15.51M), average EBITDA is $-17.954M (high $-15.506M, low $-20.402M), average net income is $-8.355M (high $-6.874M, low $-9.836M), average SG&A $62.97M (high $71.56M, low $54.38M), and average EPS is $-0.542 (high $-0.446, low $-0.638).

Did the AWH's actual financial results beat the analysts' financial forecasts?

Based on Aspira Women's Health's last annual report (Dec 2022), the company's revenue was $8.18M, which missed the average analysts forecast of $9.06M by -9.63%. Apple's EBITDA was $-38.237M, beating the average prediction of $-15.884M by 140.73%. The company's net income was $-21.575M, missing the average estimation of $-36.509M by -40.91%. Apple's SG&A was $31.13M, missing the average forecast of $31.78M by -2.03%. Lastly, the company's EPS was $-0.19, missing the average prediction of $-4.214 by -95.49%. In terms of the last quarterly report (Jun 2023), Aspira Women's Health's revenue was $2.49M, missing the average analysts' forecast of $2.8M by -11.03%. The company's EBITDA was $-4.321M, beating the average prediction of $-2.8M by 54.33%. Aspira Women's Health's net income was $-2.317M, missing the average estimation of $-8.447M by -72.57%. The company's SG&A was $5.18M, missing the average forecast of $9.82M by -47.27%. Lastly, the company's EPS was $-0.0003, missing the average prediction of $-0.548 by -99.95%